Human papillomavirus (HPV) genotypes in cervix uterine cancer patients in a public hospital and private clinic from Santiago, Chile;Genotipos de virus papiloma humano (VPH) en pacientes con cáncer cervico-uterino en un hospital público y una clínica privada de Santiago, Chile

Revista Chilena de Infectologia

Volumn 27, Issue 1, 2010, Pages 11-16

  Valdivia L , Isabel M ^a   Aguayo G , Francisco ^a   Pruyas A , Martha ^b   Peter J F , Snijders ^c   Corvalán R , Alejandro ^a   Ferreccio R , Catterina ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Genotypes; Human papillomavirus (HPV)

Indexed keywords

VIRUS DNA;

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CHILE; COMPARATIVE STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CHILE; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRIVATE SECTOR; PUBLIC SECTOR; UTERINE CERVICAL NEOPLASMS;

EID: 77953048138     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20: 207-25.
2. Ministerio de Salud Gobierno Chile. Mortalidad por causas; Serie mortalidad por causas; Tumores malignos; Cáncer del cuello uterino. [accedido octubre 2009]. Disponible en: http://www.minsal.cl/.
3. Muñoz N, Castellsagué X, de González AB, Gismann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24S3: S3/1-10.
4. IARC Monographs on the evaluation of carcinogenic risks to humans 2007 vol 90 Human papillomaviruses. Disponible en http://monographs.iarc.fr/ENG/Monographs/vol90/index.php, (accedido 12 octubre 2009).
5. Schiffman M, Herrero R, DeSalle R, Hildesheim A, Wacholder S, Rodriguez A C, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337: 76-84.
6. Gall S A. Female genital warts: global trends and treatments. Infect Dis Obstet Gynecol 2001; 9: 149-54.
7. Lowy D R, Schiller J T. Prophylactic human papillomavirus vaccines. J Clin Path 2006; 116: 1167-73.
8. Human papillomavirus (HPV) vaccine background paper. September 2009. Disponible en: http://www.who.int/immunization/documents/HPVBGpaper05032009.pdf. (accedido octubre 2009).
9. Quint W G V, Pagliusi S R, Lelie N, de Villiers E M, Wheeler C M. Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA. J Clin Micro 2006; 44: 571-79.
10. Meijer C, Berkhof J, Castle P E, Hesselink A T, Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-20.
11. Smith J S, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-32.
12. Ferreccio C, Corvalán A, Margozzini P, Viviani P, González C, Aguilera X, et al. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health 2008: 8: 78.
13. Encuesta Casen 2003. Módulo Salud. Disponible en: www.mideplan.cl. (accedido octubre 2009).
14. Estadísticas. FONASA. Disponible en www.fonasa.cl. (accedido octubre 2009).
15. Superintendencia de Salud, Diagnóstico del Sistema Isapre, Nov 2005, Disponible en: www.supersalud.cl. (accedido octubre 2009).
16. Volkenadt M, Dicker A, Fanina R, Banerje D, Albino A, Bertino J. DNA from paraffin-embedded tissue in: Methods in Molecular Biology (volumen 15) - PCR protocols current methods and applications. Bruce A. White (ed) 1993. Human Press, pp 81-8.
17. de Roda Husman A M, Walboomers J M, van de Brule A J, Meijer C J, Snijders P J. The use of general primers GP5 and GP6 elongated at their 3' adjacent highly conserved sequences improves human detection by PCR. J Gen Virol 1995; 76: 1057-62.
18. van den Brule A J, Pol R, Fransen-Daalmeijer N, Schouls L M, Meijer C J, Snijders P J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87.
19. Baay M F D, Quint W G V, Koudstaal J, Hollema H, Duk J M, Burger M P M. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-47.
20. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
21. Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 2008; 46 (3): 1050-9.
22. Clifford G, Smith J S, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.
23. Thomas D B, Ray R M, Koetsawang A, Kiviat N, Kuypers J, Qin Q, et al. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 2001; 153: 723-31.
24. Franceschi S, Plummer M, Clifford G, de Sanjosé S, Bosch X, Herrero R, et al; International Agency for Research on Cancer Multicentric Cervical Cancer Study Groups; International Agency for Research on Cancer Human Papillomavirus Prevalence Surveys Study Group. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer 2009; 101(5): 865-70.
25. de Sanjosé S, Bosch X, Muñoz N, Tafur L, Gili M, Izarzugaza I, et al. Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health 1996; 86: 1532-8.
26. Roa J C, García P, Gómez J, Fernández W, Gaete F, Espinoza A, et al. HPV genotyping from invasive cervical cancer in Chile. Int J Gynaecol Obstet 2009; 105: 150-3.
27. Larrañaga O. Eficiencia y equidad en el sistema de salud chileno (Efficiency and equity in the Chilean health care system). CEPAL/GTZ Project 1997, United Nations.
28. WHO/ICO Information Centre on Human Papilloma Virus and Cervical Cancer. [Access on April 25, 2008]. Available at. http://www.who.int/hpvcentre/en/.
29. Ferreccio C, Michael K, Waterboer T, Ojeda J M, Domínguez A, Franceschi S, et al. HPV antibodies in a population-based cohort of women. Chile 2001-2006. P-29.20 Abstract Book 25th International Papillomavirus Conference. May 8 - 14 2009 Malmö, Sweden.
30. Ferreccio C, Domínguez A, Olcay F, Puschel K, Corvalán A, Ampuero S, et al. Dynamics of HRHPV in a population-based sample of Chilean women. P-29.34 P-29.20 Abstract Book 25th International Papillomavirus Conference. May 8 - 14 2009 Malmö, Sweden.
31. Mansoura M, Toukaa M, Hasana U, Bellopedea A, Smeta A, Accardia R, et al. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development. Virology 2007; 367: 1-9.
32. Melo A, Montenegro S, Hooper T, Capurro I, Roa J C, Roa I. Human papillomavirus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX Region-Chile. Rev Méd Chile 2003; 131: 1382-90.
33. Muñoz N, Bosch F X, de Sanjosé S, Herrero R, Castellsagué X, Shah K V, et. al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
34. Pretet J L, Jacquard A C, Carcopino X, Charlot J F, Bouhour D, Kantelip B, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 2008; 122: 428-32.
35. Vermeulen C F, Jordanova E S, Szuhai K, Kolkman-Uljee S, Vrede M A, Peters A A, et al. Physical status of multiple human papilloma-virus genotypes in flow-sorted cervical cancer cells. Cancer Genet Cytogenet 2007; 175: 132-7.
36. Khair M M, Mzibri M E, Mhand R A, Benider A, Benchekroun N, Fahime E M, et al. Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women. J Med Virol 2009; 81: 678-84.
37. Sandri M T, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, et al. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol 2009; 81: 271-7.